Blockchain Registration Transaction Record

Tonix Pharmaceuticals Reports Q3 2024 Financial Results and Advances Drug Pipeline

Tonix Pharmaceuticals reports Q3 2024 financial results and highlights drug pipeline advancements for fibromyalgia, mpox vaccines, and cocaine intoxication. FDA Fast Track designation underscores commitment to CNS disorders and infectious disease treatments.

Tonix Pharmaceuticals Reports Q3 2024 Financial Results and Advances Drug Pipeline

This news matters as it highlights the progress and commitment of Tonix Pharmaceuticals in developing innovative treatments for fibromyalgia, mpox vaccines, and cocaine intoxication. The Fast Track designation from the FDA for TNX-102 SL showcases the potential impact of these treatments on patients with central nervous system disorders and infectious diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xf236c8056703d2ef1dec9c1eb10718e3ad26651130fad011b177b107060d6986
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprinticonn7yB-29dec1b320ada202c7407fd195769065